A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA

NCT06004791 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
Drug Effect

Interventions

DRUG: Herombopag + CsA
DRUG: rhTPO combined with Herombopag + CsA

Sponsor

Peking Union Medical College Hospital